CASP3 and astrocytoma (excluding glioblastoma): The treatment with dAdo and dCF in combination resulted in the activation of the apoptotic mitochondrial pathway in LoVo, human astrocytoma, and neuroblastoma cell lines [67,68,69,70] with cytochrome c release and caspase-3 activation.